MRP ₹76
(Inclusive of all Taxes)
₹11.4 Cashback (15%)
coupon
Prescription drugWhats That
Composition :
CYCLOPHOSPHAMIDE-500MG
Manufacturer/Marketer :
GLS Pharma Ltd
Consume Type :
PARENTERAL
Return Policy :
Not Returnable
Expires on or after :
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
_0.jpg?tr=q-85,f-webp,w-100,dpr-1,c-at_max "Santoshini Reddy G")
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Caution
You are recommended to avoid alcohol consumption as it may worsen the risk of cyclophosphamide-induced nausea and vomiting.
Pregnancy
Caution
It is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving CTX-GLS 500 Injection. Your doctor may prescribe this medicine only if the benefits outweigh the risks.
Breast Feeding
Unsafe
It is not recommended for use in breastfeeding as it may pass into breast milk and harm your infant. Hence, if you are breastfeeding, inform your doctor before receiving CTX-GLS 500 Injection. Avoid breastfeeding during treatment with CTX-GLS 500 Injection and for one week after the last dose.
Driving
Caution
CTX-GLS 500 Injection may cause dizziness. Do not drive or operate heavy machinery until you are alert.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving CTX-GLS 500 Injection. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Caution
If you have a history of kidney diseases, inform your doctor before receiving CTX-GLS 500 Injection. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Consult your doctor
Please consult your doctor. Your doctor will with the benefits and risks before prescribing this medicine based on your child's medical condition.
Product Substitutes
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with CTX-GLS 500 Injection:
Co-administration of Nalidixic acid with CTX-GLS 500 Injection may cause an increase in the risk of side effects.
How to manage the interaction:
Co-administration of CTX-GLS 500 Injection and Nalidixic acid can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like bruising or bleeding, unusual weakness, nausea, stomach pain, low fever, or loss of appetite, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Co-administration of Nalidixic acid with CTX-GLS 500 Injection may cause an increase in the risk of side effects.
How to manage the interaction:
Co-administration of CTX-GLS 500 Injection and Nalidixic acid can lead to an interaction, it can be taken if advised by a doctor. However, if you experience any symptoms like bruising or bleeding, unusual weakness, nausea, stomach pain, low fever, or loss of appetite, consult a doctor immediately. Do not stop using any medications without a doctor's advice.
Critical
How does the drug interact with CTX-GLS 500 Injection:
Co-administration of CTX-GLS 500 Injection and Cidofovir may increase the risk of kidney problems.
How to manage the interaction:
Taking Cyclophosphamine with Cidofovir is not recommended, please consult your doctor before taking it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm contact your doctor immediately. Do not discontinue any medications without consulting a doctor
Co-administration of CTX-GLS 500 Injection and Cidofovir may increase the risk of kidney problems.
How to manage the interaction:
Taking Cyclophosphamine with Cidofovir is not recommended, please consult your doctor before taking it. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm contact your doctor immediately. Do not discontinue any medications without consulting a doctor
How does the drug interact with CTX-GLS 500 Injection:
Using baricitinib together with CTX-GLS 500 Injection may increase the risk of serious infections.
How to manage the interaction:
Although there is an interaction, Baricitinib can be taken with CTX-GLS 500 Injection if prescribed by the doctor. However, if you experience fever, chills, diarrhea, sore throat, muscular aches, shortness of breath, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning when you urinate, consult a doctor. Do not discontinue the medication without consulting a doctor.
Using baricitinib together with CTX-GLS 500 Injection may increase the risk of serious infections.
How to manage the interaction:
Although there is an interaction, Baricitinib can be taken with CTX-GLS 500 Injection if prescribed by the doctor. However, if you experience fever, chills, diarrhea, sore throat, muscular aches, shortness of breath, blood in your coughing fluid, weight loss, red or irritated skin, body sores, and discomfort or burning when you urinate, consult a doctor. Do not discontinue the medication without consulting a doctor.
How does the drug interact with CTX-GLS 500 Injection:
Taking CTX-GLS 500 Injection with Thalidomide may increase the risk of blood clots.
How to manage the interaction:
Although there is a possible interaction, CTX-GLS 500 Injection can be taken with Thalidomide if prescribed by the doctor. However, consult the doctor if you experience chest pain, shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, and/or pain, redness, or swelling in an arm or leg. Do not discontinue any medications without a doctor's advice.
Taking CTX-GLS 500 Injection with Thalidomide may increase the risk of blood clots.
How to manage the interaction:
Although there is a possible interaction, CTX-GLS 500 Injection can be taken with Thalidomide if prescribed by the doctor. However, consult the doctor if you experience chest pain, shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, and/or pain, redness, or swelling in an arm or leg. Do not discontinue any medications without a doctor's advice.
How does the drug interact with CTX-GLS 500 Injection:
Co-administration of CTX-GLS 500 Injection and Deferiprone may increase the risk of serious and potential infections.
How to manage the interaction:
Co-administration of CTX-GLS 500 Injection with Deferiprone can possibly result in an interaction, but it can be taken if a doctor has advised it. If you're having any of these symptoms like fever, chills, sore throat, or muscle aches, it's important to contact a doctor right away. Do not discontinue any medications without consulting a doctor.
Co-administration of CTX-GLS 500 Injection and Deferiprone may increase the risk of serious and potential infections.
How to manage the interaction:
Co-administration of CTX-GLS 500 Injection with Deferiprone can possibly result in an interaction, but it can be taken if a doctor has advised it. If you're having any of these symptoms like fever, chills, sore throat, or muscle aches, it's important to contact a doctor right away. Do not discontinue any medications without consulting a doctor.
CyclophosphamideGolimumab
Severe
How does the drug interact with CTX-GLS 500 Injection:
Co-administration of Golimumab with CTX-GLS 500 Injection may increase the risk of serious infections.
How to manage the interaction:
Co-administration of CTX-GLS 500 Injection with Golimumab can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, weight loss, pain or burning during urination. Do not stop using any medications without a doctor's advice.
Co-administration of Golimumab with CTX-GLS 500 Injection may increase the risk of serious infections.
How to manage the interaction:
Co-administration of CTX-GLS 500 Injection with Golimumab can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, weight loss, pain or burning during urination. Do not stop using any medications without a doctor's advice.
How does the drug interact with CTX-GLS 500 Injection:
Taking CTX-GLS 500 Injection with Leflunomide may increase the risk of serious infections.
How to manage the interaction:
Although there is a possible interaction, CTX-GLS 500 Injection can be taken with Leflunomide if prescribed by the doctor. Consult the doctor immediately if you develop signs and symptoms of infection such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Do not discontinue the medication without consulting a doctor.
Taking CTX-GLS 500 Injection with Leflunomide may increase the risk of serious infections.
How to manage the interaction:
Although there is a possible interaction, CTX-GLS 500 Injection can be taken with Leflunomide if prescribed by the doctor. Consult the doctor immediately if you develop signs and symptoms of infection such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Do not discontinue the medication without consulting a doctor.
How does the drug interact with CTX-GLS 500 Injection:
When Adalimumab is taken with CTX-GLS 500 Injection, may increase the risk of serious infections.
How to manage the interaction:
Although taking CTX-GLS 500 Injection and Adalimumab together can evidently cause an interaction, it can be taken if a doctor has suggested it. If you have any of these symptoms such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Do not stop using any medications without a doctor's advice.
When Adalimumab is taken with CTX-GLS 500 Injection, may increase the risk of serious infections.
How to manage the interaction:
Although taking CTX-GLS 500 Injection and Adalimumab together can evidently cause an interaction, it can be taken if a doctor has suggested it. If you have any of these symptoms such as fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, and pain or burning during urination. Do not stop using any medications without a doctor's advice.
How does the drug interact with CTX-GLS 500 Injection:
Coadministration of Tenofovir disoproxil with CTX-GLS 500 Injection may increase the risk of developing kidney problems.
How to manage the interaction:
Although there is a possible interaction, CTX-GLS 500 Injection can be taken with Tenofovir disoproxil if prescribed by the doctor. Consult the doctor if you experience signs and symptoms of kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medication without consulting a doctor.
Coadministration of Tenofovir disoproxil with CTX-GLS 500 Injection may increase the risk of developing kidney problems.
How to manage the interaction:
Although there is a possible interaction, CTX-GLS 500 Injection can be taken with Tenofovir disoproxil if prescribed by the doctor. Consult the doctor if you experience signs and symptoms of kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medication without consulting a doctor.
Severe
How does the drug interact with CTX-GLS 500 Injection:
Co-administration of CTX-GLS 500 Injection with Busulfan can increase the risk of side effects.
How to manage the interaction:
Although there is an interaction between Busulfan and CTX-GLS 500 Injection, they can be taken together if prescribed by a doctor. However, if you experience any vomiting, diarrhea, mouth sores, or stomach pain, contact your doctor immediately. Do not stop using any medications without talking to your doctor.
Co-administration of CTX-GLS 500 Injection with Busulfan can increase the risk of side effects.
How to manage the interaction:
Although there is an interaction between Busulfan and CTX-GLS 500 Injection, they can be taken together if prescribed by a doctor. However, if you experience any vomiting, diarrhea, mouth sores, or stomach pain, contact your doctor immediately. Do not stop using any medications without talking to your doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
CYCLOPHOSPHAMIDE-500MGOther diseases of blood and blood-forming organs
Severe
CYCLOPHOSPHAMIDE-500MGObstructive and reflux uropathy
Severe
Drug-Diseases Interactions
Login/Sign Up
CYCLOPHOSPHAMIDE-500MGOther diseases of blood and blood-forming organs
Severe
How does the disease interact with CTX-GLS 500 Injection:
CTX-GLS 500 Injection usage can result in severe immunosuppression, bone marrow failure, myelosuppression (leukopenia, neutropenia, thrombocytopenia, and anaemia), and myelosuppression, which can all lead to serious and occasionally deadly infections including sepsis and septic shock. During CTX-GLS 500 Injection treatment, complete blood counts must be closely monitored in order to determine whether the dose has to be changed. Patients should not be given CTX-GLS 500 Injection if their neutrophil and platelet counts are below 1,500/mm3 and 50,000/mm3, respectively.
How to manage the interaction:
Close monitoring of complete blood count is advised during treatment with CTX-GLS 500 Injection. Inform the doctor if you notice any signs or symptoms of bone marrow suppression such as fever, sore throat, local infection, or bleeding.
CTX-GLS 500 Injection usage can result in severe immunosuppression, bone marrow failure, myelosuppression (leukopenia, neutropenia, thrombocytopenia, and anaemia), and myelosuppression, which can all lead to serious and occasionally deadly infections including sepsis and septic shock. During CTX-GLS 500 Injection treatment, complete blood counts must be closely monitored in order to determine whether the dose has to be changed. Patients should not be given CTX-GLS 500 Injection if their neutrophil and platelet counts are below 1,500/mm3 and 50,000/mm3, respectively.
How to manage the interaction:
Close monitoring of complete blood count is advised during treatment with CTX-GLS 500 Injection. Inform the doctor if you notice any signs or symptoms of bone marrow suppression such as fever, sore throat, local infection, or bleeding.
CYCLOPHOSPHAMIDE-500MGObstructive and reflux uropathy
Severe
How does the disease interact with CTX-GLS 500 Injection:
CTX-GLS 500 Injection should not be administered to individuals who have any type of urine outflow restriction. Urinary blockage should be ruled out or resolved before therapy is started. During CTX-GLS 500 Injection treatment, hemorrhagic cystitis, pyelitis, and hematuria have all been mentioned.
How to manage the interaction:
Therapy with CTX-GLS 500 Injection should be administered cautiously in patients with or predisposed to bladder inflammation, including patients with active urinary infections. Urinary sediment should be monitored regularly for presence or erythrocytes and other signs of toxicity.
CTX-GLS 500 Injection should not be administered to individuals who have any type of urine outflow restriction. Urinary blockage should be ruled out or resolved before therapy is started. During CTX-GLS 500 Injection treatment, hemorrhagic cystitis, pyelitis, and hematuria have all been mentioned.
How to manage the interaction:
Therapy with CTX-GLS 500 Injection should be administered cautiously in patients with or predisposed to bladder inflammation, including patients with active urinary infections. Urinary sediment should be monitored regularly for presence or erythrocytes and other signs of toxicity.
CYCLOPHOSPHAMIDE-500MGObstructive and reflux uropathy
Severe
How does the disease interact with CTX-GLS 500 Injection:
CTX-GLS 500 Injection should not be administered to individuals who have any type of urine outflow restriction. Urinary blockage should be ruled out or resolved before therapy is started. During CTX-GLS 500 Injection treatment, hemorrhagic cystitis, pyelitis, and hematuria have all been mentioned.
How to manage the interaction:
Therapy with CTX-GLS 500 Injection should be administered cautiously in patients with or predisposed to bladder inflammation, including patients with active urinary infections. Urinary sediment should be monitored regularly for presence or erythrocytes and other signs of toxicity.
CTX-GLS 500 Injection should not be administered to individuals who have any type of urine outflow restriction. Urinary blockage should be ruled out or resolved before therapy is started. During CTX-GLS 500 Injection treatment, hemorrhagic cystitis, pyelitis, and hematuria have all been mentioned.
How to manage the interaction:
Therapy with CTX-GLS 500 Injection should be administered cautiously in patients with or predisposed to bladder inflammation, including patients with active urinary infections. Urinary sediment should be monitored regularly for presence or erythrocytes and other signs of toxicity.
CYCLOPHOSPHAMIDE-500MGObstructive and reflux uropathy
Severe
How does the disease interact with CTX-GLS 500 Injection:
CTX-GLS 500 Injection should not be administered to individuals who have any type of urine outflow restriction. Urinary blockage should be ruled out or resolved before therapy is started. During CTX-GLS 500 Injection treatment, hemorrhagic cystitis, pyelitis, and hematuria have all been mentioned.
How to manage the interaction:
Therapy with CTX-GLS 500 Injection should be administered cautiously in patients with or predisposed to bladder inflammation, including patients with active urinary infections. Urinary sediment should be monitored regularly for presence or erythrocytes and other signs of toxicity.
CTX-GLS 500 Injection should not be administered to individuals who have any type of urine outflow restriction. Urinary blockage should be ruled out or resolved before therapy is started. During CTX-GLS 500 Injection treatment, hemorrhagic cystitis, pyelitis, and hematuria have all been mentioned.
How to manage the interaction:
Therapy with CTX-GLS 500 Injection should be administered cautiously in patients with or predisposed to bladder inflammation, including patients with active urinary infections. Urinary sediment should be monitored regularly for presence or erythrocytes and other signs of toxicity.
Have a query?